---
title: "acrivastine - Allergic conjunctivitis"
sidebar: mydoc_sidebar
permalink: acrivastineallergicconjunctivitis.html
toc: false 
---

{% include image.html file="acrivastineallergicconjunctivitis.png" alt="acrivastineallergicconjunctivitis" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C043648 | acrivastine | Drug |
| UniProt:P35367 | Histamine H1 receptor | Protein |
| GO:0034776 | response to histamine | BiologicalProcess |
| REACT:R-HSA-388396 | GPCR downstream signalling | Pathway |
| UniProt:P19838 | Nuclear factor NF-kappa-B p105 subunit | Protein |
| GO:0006954 | inflammatory response | BiologicalProcess |
| HP:0000969 | Edema | PhenotypicFeature |
| MESH:D003233 | Allergic conjunctivitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Acrivastine | DECREASES ACTIVITY OF | Histamine H1 Receptor |
| Histamine H1 Receptor | PARTICIPATES IN | Response To Histamine |
| Response To Histamine | INCREASES ACTIVITY OF | Gpcr Downstream Signalling |
| Gpcr Downstream Signalling | INCREASES ACTIVITY OF | Nuclear Factor Nf-Kappa-B P105 Subunit |
| Nuclear Factor Nf-Kappa-B P105 Subunit | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | CONTRIBUTES TO | Edema |
| Edema | MANIFESTATION OF | Allergic Conjunctivitis |
|---------|-----------|---------|

Reference: [https://go.drugbank.com/drugs/DB09488#mechanism-of-action](https://go.drugbank.com/drugs/DB09488#mechanism-of-action){:target="_blank"}